Novartis Sued by U.S. for Fraud Over Payments to Pharmaci

Novartis AG was sued by the U.S. for alleged health-care fraud, saying the company paid kickbacks to pharmacies for switching transplant patients to its drug Myfortic.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.